← Back to Search

Mesh Implant

Mesh Implantation for Colon Cancer (SCAR Trial)

N/A

Waitlist Available

Led By Matthew Z Wilson, MD, Msc

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

SCAR Trial Summary

This trial will test a new technique to help prevent hernias at sites of ostomy closures.

Eligible Conditions

Colon Cancer
Ileostomy
Colorectal Cancer

SCAR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants With Wound Occurrences

Number of Participants With Wound Occurrences in Current Study Compared to Historical Controls

Secondary outcome measures

Bowel Function After Mesh Implantation

Diaphragmatic Hernia

Quality of Life After Mesh Implantation

SCAR Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Patients undergoing mesh implantation during ileostomy closure to reinforce the abdominal wall

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mesh Implantation

2006

N/A

~100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Hitchcock FoundationOTHER

1 Previous Clinical Trials

19 Total Patients Enrolled

Dartmouth-Hitchcock Medical CenterLead Sponsor

524 Previous Clinical Trials

2,543,319 Total Patients Enrolled

The Hitchcock FoundationUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why was this clinical trial designed and what goals does it hope to achieve?

"The purpose of this 30-day trial is to compare the incidence of wound occurrences in current study compared to historical controls. Secondary outcomes include bowel function after mesh implantation, as measured by the Colorectal Function Outcome (COREFO) instrument, and the incidence of hernia formation at the ileostomy site. Quality of life after mesh implantation will be measured by the Promis SF 2.0 8a Ability to Participate in Social Roles and Activities instrument."

Answered by AI

Are there any available spots for participants in this trial?

"According to the website clinicaltrials.gov, this particular trial is no longer recruiting patients. The listing for this study was first posted on January 1st, 2019 and was last updated on February 15th, 2022. Currently, there are 569 other trials that are actively recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Stoma Closure and Reinforcement Trial

Matthew Z. Wilson 2019. "Stoma Closure and Reinforcement Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03750461.